Moneycontrol
SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
127.995 0.29 (0.23%)

NAV as on 12 Dec, 2017

CRISIL MF RANK

Not Ranked

Riskometer

HIGH

HIGH

  • Principal at high risk.
FUND FAMILY : SBI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Holdings (Oct 31, 17)
Equity Sector Value
(Rs cr)
Assets %
Cipla Pharmaceuticals 107.95 10.24
Divis Labs Pharmaceuticals 105.90 10.05
Aurobindo Pharm Pharmaceuticals 102.60 9.74
Strides Shasun Pharmaceuticals 74.59 7.08
Dr Reddys Labs Pharmaceuticals 72.84 6.91
Natco Pharma Pharmaceuticals 61.96 5.88
Cadila Health Pharmaceuticals 60.41 5.73
Alkem Lab Pharmaceuticals 46.85 4.44
Torrent Pharma Pharmaceuticals 45.71 4.34
Thyrocare Techn Services 41.52 3.94
Sector Allocation (Oct 31, 17)
  Sector   % 1-Year
High Low

Pharmaceuticals

88.27 0.00 0.00

Services

9.23 0.00 0.00
Asset Allocation (%) (Oct 31, 17)
Class
%

Equity

97.50

Others / Unlisted

0.02

Debt

0.00

Mutual Funds

N.A

Money Market

2.94

Cash / Call

-0.46

Net Receivable / Payable

N.A
Concentration
Holdings
%

Top 5

44.02

Top 10

68.35
Sectors
%

Top 3

97.50
Sections
Follow us on
Available On